FDA Approved: AYVAKIT — Original Application (Blueprint Medicines Corporation)

View source ↗

Summary

FDA approved AYVAKIT (avapritinib) under the original NDA for adults with unresectable or metastatic gastrointestinal stromal tumors harboring the PDGFRA exon 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• AYVAKIT (avapritinib)

Snippet

ORIG AP for AYVAKIT (AVAPRITINIB)